BRAINSWAY LTD-ADR (BWAY) Stock Fundamental Analysis
USA - NASDAQ:BWAY - US10501L1061 - ADR
16 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to BWAY. BWAY was compared to 191 industry peers in the Health Care Equipment & Supplies industry. BWAY is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BWAY has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination! These ratings would make BWAY suitable for value and growth investing!
1. Profitability
1.1 Basic Checks
BWAY had positive earnings in the past year.
BWAY had a positive operating cash flow in the past year.
BWAY had negative earnings in 4 of the past 5 years.
In multiple years BWAY reported negative operating cash flow during the last 5 years.
1.2 Ratios
With an excellent Return On Assets value of 4.79%, BWAY belongs to the best of the industry, outperforming 81.68% of the companies in the same industry.
BWAY has a better Return On Equity (7.84%) than 81.68% of its industry peers.
BWAY has a Return On Invested Capital of 1.83%. This is in the better half of the industry: BWAY outperforms 69.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.79% | ||
| ROE | 7.84% | ||
| ROIC | 1.83% |
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 11.60%, BWAY belongs to the top of the industry, outperforming 86.91% of the companies in the same industry.
BWAY has a Operating Margin of 4.05%. This is in the better half of the industry: BWAY outperforms 68.59% of its industry peers.
BWAY's Gross Margin of 74.52% is amongst the best of the industry. BWAY outperforms 86.39% of its industry peers.
BWAY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.05% | ||
| PM (TTM) | 11.6% | ||
| GM | 74.52% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BWAY is destroying value.
The number of shares outstanding for BWAY has been increased compared to 1 year ago.
BWAY has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BWAY is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.25 indicates that BWAY is not in any danger for bankruptcy at the moment.
BWAY's Altman-Z score of 4.25 is fine compared to the rest of the industry. BWAY outperforms 75.92% of its industry peers.
The Debt to FCF ratio of BWAY is 0.33, which is an excellent value as it means it would take BWAY, only 0.33 years of fcf income to pay off all of its debts.
BWAY has a better Debt to FCF ratio (0.33) than 93.19% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that BWAY is not too dependend on debt financing.
BWAY has a Debt to Equity ratio of 0.08. This is in the better half of the industry: BWAY outperforms 65.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.33 | ||
| Altman-Z | 4.25 |
ROIC/WACC0.21
WACC8.76%
2.3 Liquidity
BWAY has a Current Ratio of 3.51. This indicates that BWAY is financially healthy and has no problem in meeting its short term obligations.
BWAY has a better Current ratio (3.51) than 65.44% of its industry peers.
BWAY has a Quick Ratio of 3.34. This indicates that BWAY is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of BWAY (3.34) is better than 69.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.51 | ||
| Quick Ratio | 3.34 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 1178.38% over the past year.
Looking at the last year, BWAY shows a very strong growth in Revenue. The Revenue has grown by 26.50%.
The Revenue has been growing by 12.17% on average over the past years. This is quite good.
EPS 1Y (TTM)1178.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%141.89%
Revenue 1Y (TTM)26.5%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%21.26%
3.2 Future
BWAY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 53.27% yearly.
Based on estimates for the next years, BWAY will show a quite strong growth in Revenue. The Revenue will grow by 19.29% on average per year.
EPS Next Y58.83%
EPS Next 2Y54.54%
EPS Next 3Y53.27%
EPS Next 5YN/A
Revenue Next Year15%
Revenue Next 2Y18.5%
Revenue Next 3Y19.29%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 15.84, BWAY is valued correctly.
Based on the Price/Earnings ratio, BWAY is valued cheaply inside the industry as 85.34% of the companies are valued more expensively.
BWAY is valuated rather cheaply when we compare the Price/Earnings ratio to 27.40, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 10.61, which indicates a very decent valuation of BWAY.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BWAY indicates a rather cheap valuation: BWAY is cheaper than 92.67% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.94, BWAY is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.84 | ||
| Fwd PE | 10.61 |
4.2 Price Multiples
BWAY's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BWAY is cheaper than 64.92% of the companies in the same industry.
90.05% of the companies in the same industry are more expensive than BWAY, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.24 | ||
| EV/EBITDA | 58.46 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BWAY's earnings are expected to grow with 53.27% in the coming years.
PEG (NY)0.27
PEG (5Y)N/A
EPS Next 2Y54.54%
EPS Next 3Y53.27%
5. Dividend
5.1 Amount
BWAY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:BWAY (10/17/2025, 8:00:02 PM)
16
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners5.13%
Inst Owner Change0%
Ins Owners16.62%
Ins Owner ChangeN/A
Market Cap304.06M
Analysts85.71
Price Target0.11 (-99.31%)
Short Float %1.31%
Short Ratio3.08
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)36.24%
Min EPS beat(2)-22.64%
Max EPS beat(2)95.12%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.21%
Min Revenue beat(2)-2.35%
Max Revenue beat(2)-0.08%
Revenue beat(4)2
Avg Revenue beat(4)-0.57%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)0.15%
Revenue beat(8)5
Avg Revenue beat(8)0.76%
Revenue beat(12)6
Avg Revenue beat(12)-18.08%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)16.16%
PT rev (3m)39.25%
EPS NQ rev (1m)-27.15%
EPS NQ rev (3m)-22.66%
EPS NY rev (1m)-27.15%
EPS NY rev (3m)-12.41%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)-2.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.84 | ||
| Fwd PE | 10.61 | ||
| P/S | 6.6 | ||
| P/FCF | 16.24 | ||
| P/OCF | 13.13 | ||
| P/B | 4.46 | ||
| P/tB | 4.46 | ||
| EV/EBITDA | 58.46 |
EPS(TTM)1.01
EY6.31%
EPS(NY)1.51
Fwd EY9.42%
FCF(TTM)0.99
FCFY6.16%
OCF(TTM)1.22
OCFY7.62%
SpS2.43
BVpS3.59
TBVpS3.59
PEG (NY)0.27
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.79% | ||
| ROE | 7.84% | ||
| ROCE | 2.17% | ||
| ROIC | 1.83% | ||
| ROICexc | 19.56% | ||
| ROICexgc | 19.56% | ||
| OM | 4.05% | ||
| PM (TTM) | 11.6% | ||
| GM | 74.52% | ||
| FCFM | 40.64% |
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
F-Score4
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.33 | ||
| Debt/EBITDA | 1.37 | ||
| Cap/Depr | 229.33% | ||
| Cap/Sales | 9.62% | ||
| Interest Coverage | 11.81 | ||
| Cash Conversion | 609.66% | ||
| Profit Quality | 350.45% | ||
| Current Ratio | 3.51 | ||
| Quick Ratio | 3.34 | ||
| Altman-Z | 4.25 |
F-Score4
WACC8.76%
ROIC/WACC0.21
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1178.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%141.89%
EPS Next Y58.83%
EPS Next 2Y54.54%
EPS Next 3Y53.27%
EPS Next 5YN/A
Revenue 1Y (TTM)26.5%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%21.26%
Revenue Next Year15%
Revenue Next 2Y18.5%
Revenue Next 3Y19.29%
Revenue Next 5YN/A
EBIT growth 1Y155.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-6.13%
EBIT Next 3Y41.44%
EBIT Next 5YN/A
FCF growth 1Y321.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y429.93%
OCF growth 3Y127.03%
OCF growth 5YN/A